Breastfeeding does not cause breast cancer. It actually reduces the risk. Each 12 months of breastfeeding lowers breast cancer risk by about 4.3%, and that benefit stacks on top of a separate 7% risk reduction from each pregnancy. So a woman who has two children and breastfeeds each for 12 months reduces her overall breast cancer risk by roughly 8.6% from breastfeeding alone, plus 14% from the pregnancies themselves.
The confusion likely comes from the fact that breast changes during lactation can feel alarming, and in rare cases, breast cancer is discovered during the postpartum period. But breastfeeding itself is protective, not harmful.
How Breastfeeding Protects Against Breast Cancer
Several biological processes work together during lactation to lower cancer risk. The most significant involves hormones. When you breastfeed, your body suppresses ovulation through the hormone prolactin, which is responsible for milk production. Less ovulation means lower cumulative exposure to estrogen, a hormone that fuels the growth of many breast cancers. With less estrogen circulating, breast cells proliferate more slowly, reducing the window for something to go wrong at the genetic level.
The second mechanism is more physical. During lactation, breast tissue cycles through milk production, expansion of the milk ducts, and then involution (the process of returning to a non-lactating state after weaning). This constant remodeling effectively clears out cells that may have accumulated DNA damage. Think of it as a deep clean: potentially mutated cells get shed and replaced, reducing the chance that a damaged cell sticks around long enough to become cancerous.
Protection Against Aggressive Subtypes
The protective effect is especially notable for triple-negative breast cancer, an aggressive subtype that’s harder to treat because it doesn’t respond to hormone-blocking therapies. Research published in npj Breast Cancer estimates that up to 15% of new triple-negative breast cancers in Black women and 12% in White women could be prevented if breastfeeding rates improved. Women who never breastfed had roughly 1.4 to 2 times the odds of developing triple-negative breast cancer compared to those who breastfed for more than six months.
This is particularly relevant given that breastfeeding rates differ by race. About 74% of Black women in the U.S. report ever breastfeeding, compared to 85% of White women. At six months, only 44% of Black women are still breastfeeding versus 60% of White women. These gaps in breastfeeding duration may contribute to disparities in triple-negative breast cancer rates.
What About BRCA Gene Carriers?
If you carry a BRCA1 mutation, breastfeeding offers an outsized benefit. Women with BRCA1 mutations who breastfed for at least one year saw a 32% reduction in breast cancer risk. Those who breastfed for two or more years cut their risk roughly in half. That’s a much larger effect than the 4.3% per year seen in the general population, likely because BRCA1 cancers tend to be estrogen-sensitive in ways that respond strongly to the hormonal changes of lactation.
For BRCA2 carriers, the picture is different. Studies have found no significant association between breastfeeding duration and breast cancer risk in this group. The biological pathway for BRCA2-related cancers appears to be different enough that the hormonal shifts of breastfeeding don’t offer the same protection. This doesn’t mean breastfeeding is harmful for BRCA2 carriers. It simply doesn’t appear to move the needle on cancer risk specifically.
Premenopausal vs. Postmenopausal Risk
The protective effect of breastfeeding appears strongest for premenopausal or early-onset breast cancer. Multiple large cohort studies have found no association between breastfeeding and postmenopausal breast cancer risk. This makes biological sense: the hormonal suppression that breastfeeding provides matters most during the years when estrogen levels are naturally high. After menopause, when estrogen drops on its own, the additional suppression from past breastfeeding becomes less relevant.
Breast Cancer Discovered During Breastfeeding
While breastfeeding doesn’t cause breast cancer, it is possible for breast cancer to be diagnosed during the postpartum period. Pregnancy-associated breast cancer occurs in roughly 19 out of every 100,000 pregnancies globally, and about two-thirds of those cases are diagnosed after delivery rather than during pregnancy. The incidence has risen over decades, from about 13 cases per 100,000 in 1969 to 19 per 100,000 today, likely reflecting the trend toward having children at older ages.
This timing creates a specific challenge: the normal changes of lactating breasts (engorgement, lumps from clogged ducts, tenderness) can mask or mimic signs of cancer. Inflammatory breast cancer, in particular, looks a lot like mastitis. Both cause redness, swelling, warmth, and pain. The key difference is how the symptoms respond to treatment. If antibiotics clear things up within a week or two, it’s almost certainly an infection. If the redness and swelling persist despite antibiotics, that warrants further investigation, including a tissue biopsy.
Screening Accuracy During Lactation
If you or your doctor notice something concerning while breastfeeding, imaging still works well. Mammography during lactation has 100% sensitivity (it catches all cancers present) and 93% specificity (it correctly identifies most non-cancerous findings). Ultrasound performs similarly, with 100% sensitivity and 86% specificity. Neither test requires you to stop breastfeeding.
If a biopsy is needed, that’s also safe during lactation. There’s no need to stop breastfeeding before or after an ultrasound-guided core needle biopsy. The risk of developing a milk fistula (a persistent leak from the biopsy site) is under 2%. The main precaution is to continue breastfeeding normally rather than pumping aggressively afterward, since overpumping can worsen milk supply issues and actually promote fistula formation. Milk may be slightly blood-tinged for a few days after a biopsy, but it’s safe for the baby.
How Long You Need to Breastfeed for Protection
The 4.3% reduction per 12 months is a cumulative, dose-dependent effect. Longer breastfeeding provides greater protection. For the general population, even six months offers measurable benefit, particularly against triple-negative breast cancer. For BRCA1 carriers, the threshold for significant protection appears to be around 12 months, with the greatest benefit at 24 months or more.
These numbers are cumulative across all children, not per child. If you breastfeed one child for six months and another for six months, that counts as 12 months total. The protection adds to, and is separate from, the risk reduction that comes from pregnancy itself.